Public Release: 

Future ScienceOA explores nitric oxide in medicine: Where are we, and where are we headed?

Special issue of Future Science OA examines current research in Nitric Oxide, focusing on delivery and detection strategies in medicine

Future Science Group


IMAGE: This is the journal cover image. view more

Credit: Future Science Group

Future Science Group (FSG) today announced the publication of a special issue in Future Science OA, covering the rapidly evolving field of nitric oxide (NO) in human medicine.

Since the revelation in 1987 that NO was the elusive endothelium-derived relaxing factor, we have seen research rapidly expand, with new questions, limitations and controversies arising at a steady pace.

Adam J Friedman (George Washington School of Medicine and Health Sciences, USA) and Joel M Friedman (Albert Einstein College of Medicine, USA), Guest Editors of the issue, explained: "The world of NO biology and translational development is massive and expanding every day. The mission of this special issue is to, first, provide a practical and clinically oriented glimpse into how NO plays such a tremendous role in human biology and, second yet more importantly, review how we can capitalize on this information to impact medical/surgical care through the development of technologies designed to deliver this highly potent yet short-lived biomolecule in a meaningful way."

The Future Science OA issue includes a series of reports written by experts at the cutting edge of the field, focusing on harnessing this important molecule. Beginning with an overview of the relevant chemical and physical properties of NO, the issue goes on to explore ongoing challenges in our understanding of its role and use in human health, such as quantification, delivery and generation. There follows a series of reports into specific disease areas, such as its cancer- and cardiovascular-related applications, among others.

"With the explosion we have seen in NO research looking to capture its impressive therapeutic potential, it is important to take a step back and take a look at the field as a whole," noted Francesca Lake, Managing Editor. "We hope this issue will stimulate discussion and lead to further research, improving our understanding of how we can utilize this modest biomolecule"


Click here: to access the special issue in Future Science OA.

About Future Science OA

Launched in March 2015, Future Science OA is the inaugural gold open access journal from Future Science Group. It publishes articles covering research of application to human health, and utilizes a CC-BY license. Future Science OA embraces the importance of publishing all good-quality research with the potential to further the progress of medical science. Negative and early-phase research will be considered. The journal also features review articles, editorials and perspectives, providing readers with a leading source of commentary and analysis.

About Future Science Group

Founded in 2001, Future Science Group (FSG) is a progressive publisher focused on breakthrough medical, biotechnological, and scientific research. FSG's portfolio includes two imprints, Future Science and Future Medicine. In addition to this core publishing business, FSG develops specialist eCommunities. Key titles and sites include Bioanalysis Zone, Epigenomics, Nanomedicine and the award-winning Regenerative Medicine.

The aim of FSG is to service the advancement of clinical practice and drug research by enhancing the efficiency of communications among clinicians, researchers and decision-makers, and by providing innovative solutions to their information needs. This is achieved through a customer-centric approach, use of new technologies, products that deliver value-for-money and uncompromisingly high standards.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.